Shanghai - Delayed Quote CNY

Xiamen Amoytop Biotech Co., Ltd. (688278.SS)

Compare
80.88
+0.79
+(0.99%)
At close: January 27 at 3:00:02 PM GMT+8
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,595,233.85
2,100,322.88
1,526,905.12
1,132,227.71
793,934.30
Cost of Revenue
176,367.37
140,054.36
169,239.03
125,133.85
83,649.45
Gross Profit
2,418,866.48
1,960,268.52
1,357,666.10
1,007,093.86
710,284.86
Operating Expense
1,542,244.81
1,275,859.49
959,542.11
767,351.82
556,655.04
Operating Income
876,621.67
684,409.03
398,123.98
239,742.04
153,629.81
Net Non Operating Interest Income Expense
4,626.13
5,842.94
3,701.10
1,560.99
96.32
Pretax Income
838,734.52
640,654.49
355,925.84
215,285.99
139,067.21
Tax Provision
98,042.25
85,205.08
68,905.92
34,085.03
22,497.63
Net Income Common Stockholders
740,692.27
555,449.41
287,019.92
181,200.96
116,569.58
Basic EPS
1.82
1.37
0.71
0.45
0.29
Diluted EPS
1.82
1.37
0.71
0.45
0.29
Basic Average Shares
406,990.82
405,437.53
404,253.41
402,668.80
401,964.07
Diluted Average Shares
406,990.82
405,437.53
404,253.41
402,668.80
401,964.07
Total Operating Income as Reported
872,982.40
680,720.48
406,924.31
248,528.39
158,140.35
Rent Expense Supplemental
--
5,733.86
4,208.14
2,743.00
2,435.30
Total Expenses
1,718,612.18
1,415,913.85
1,128,781.14
892,485.67
640,304.49
Net Income from Continuing & Discontinued Operation
740,692.27
555,449.41
287,019.92
181,200.96
116,569.58
Normalized Income
750,235.13
565,893.78
286,132.99
178,921.40
112,814.73
Interest Income
4,166.68
6,627.01
4,569.06
2,851.65
2,782.64
Interest Expense
492.17
506.17
620.73
1,074.49
2,462.43
Net Interest Income
4,626.13
5,842.94
3,701.10
1,560.99
96.32
EBIT
839,226.69
641,160.66
356,546.57
216,360.48
141,529.64
EBITDA
839,226.69
699,854.48
404,621.31
259,512.94
179,697.91
Reconciled Cost of Revenue
176,367.37
140,054.36
169,239.03
125,133.85
83,649.45
Reconciled Depreciation
--
58,693.82
48,074.74
43,152.45
38,168.27
Net Income from Continuing Operation Net Minority Interest
740,692.27
555,449.41
287,019.92
181,200.96
116,569.58
Total Unusual Items Excluding Goodwill
-10,806.00
-12,046.52
1,099.86
2,708.36
4,479.53
Total Unusual Items
-10,806.00
-12,046.52
1,099.86
2,708.36
4,479.53
Normalized EBITDA
850,032.70
711,900.99
403,521.45
256,804.58
175,218.38
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-1,263.15
-1,602.15
212.93
428.80
724.68
12/31/2020 - 1/17/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NKGNW NKGen Biotech, Inc.
0.1141
+14.10%
 
SABSW SAB Biotherapeutics, Inc.
0.0368
+15.00%
 
WXXWY WuXi Biologics (Cayman) Inc.
4.7800
+0.63%
 
TFFP TFF Pharmaceuticals, Inc.
0.0650
-60.05%
 
MTVA MetaVia Inc.
1.8100
-8.12%
 
XBIO Xenetic Biosciences, Inc.
4.3100
+0.70%
 
IMTX Immatics N.V.
5.47
+1.30%
 
VTVT vTv Therapeutics Inc.
16.19
+10.21%
 
IMAB I-Mab
1.0200
-3.77%
 
INAB IN8bio, Inc.
0.2558
+3.19%